| Disease | liver neoplasms |
| Phenotype | C0028754|obesity |
| Sentences | 2 |
| PubMedID- 25879666 | Therefore, metformin may be a potent candidate for chemoprevention of liver tumorigenesis in patients with obesity or diabetes. |
| PubMedID- 24273224 | Furthermore, acr and bcaa inhibit liver tumorigenesis associated with obesity and diabetes, both of which are critical risk factors for hcc development. |
Page: 1